美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70748-103-06	70748-103	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211579	Lupin Pharmaceuticals, Inc.	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	10 mg/1; 500 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70748-103-06)
70748-104-06	70748-104	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211579	Lupin Pharmaceuticals, Inc.	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	10 mg/1; 1000 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70748-104-06)
70748-101-06	70748-101	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211579	Lupin Pharmaceuticals, Inc.	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5 mg/1; 500 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70748-101-06)
70748-102-07	70748-102	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20260406	N/A	ANDA	ANDA211579	Lupin Pharmaceuticals, Inc.	DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5 mg/1; 1000 mg/1	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70748-102-07)